NCT04229420

Brief Summary

This randomized, controlled study is designed to assess the quality of analgesia provided by ultrasound guided ESPB versus RSB in adults undergoing major abdominal surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
56

participants targeted

Target at P25-P50 for not_applicable pain

Timeline
Completed

Started Jan 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2020

Completed
11 days until next milestone

First Submitted

Initial submission to the registry

January 12, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

January 18, 2020

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2021

Completed
Last Updated

March 16, 2021

Status Verified

March 1, 2021

Enrollment Period

1.2 years

First QC Date

January 12, 2020

Last Update Submit

March 14, 2021

Conditions

Keywords

erector spinaeultrasoundrectus sheathpain

Outcome Measures

Primary Outcomes (1)

  • Time to first request of postoperative rescue analgesics

    the time interval between the block performance and the first request to postoperative analgesia and or VAS ≥ 4

    24 hours

Secondary Outcomes (5)

  • Visual analogue score at rest (static), and on movement or coughing (dynamic)

    24 hours

  • Total consumption of morphine

    24 hours

  • Incidence of perioperative complications.

    24 hours

  • Block performance time in min

    procedure (time from probe contact with skin till needle withdrawal)

  • Failure rate of the block

    1st postoperative hour

Study Arms (2)

Rectus sheath block group (RSB)

ACTIVE COMPARATOR

After preparing the skin, a high frequency (5-10 MHz) ultrasound probe will be placed in a longitudinal orientation above the level of the umbilicus with the Patient in the supine position. After identifying the rectus abdominis muscle, A 22 G echogenic needle using the in plane technique will be inserted just below the costal margin then, a total of 20 ml of 0.25% bupivacaine will be injected into the plane between the rectus muscle and posterior rectus sheath. Negative aspiration will be confirmed every 5 ml. The block will then be repeated on the other side.

Device: Ultrasound guided Rectus sheath block vs Erector spinae plane block

Erector spinae plane block group (ESPB)

ACTIVE COMPARATOR

After induction of anesthesia; the patient will be positioned on the lateral position. The skin will be prepared with povidone iodine, and a high frequency (5-10 MHz) ultrasound probewill be placed in a transverse orientation on the T9 spinous process which will be located by palpating and counting down from the C7 spinous process. The tip of the T9 transverse process will be identified and centred on the ultrasound screen, the probe will then be rotated into a longitudinal orientation to produce a parasagittal view. Correct location of the needle tip in the fascial plane deep to erector spinae muscle is confirmed by injecting 0.5-1 ml saline and seeing the fluid lifting the erector spinae muscle off the transverse process while not distending the muscle. A total of 20 ml of 0.25% bupivacaine will then be injected into the ESP of both sides.

Device: Ultrasound guided Rectus sheath block vs Erector spinae plane block

Interventions

Ultrasound guided Rectus sheath block vs Erector spinae plane block

Erector spinae plane block group (ESPB)Rectus sheath block group (RSB)

Eligibility Criteria

Age18 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • ASA physical status I-II. Age: 18 to 60 years. Undergoing midline vertical laparotomy incisions (open colorectal resections or major ventral hernia repair).

You may not qualify if:

  • Refusal of patients.
  • Patients with coagulation disorders (Platelets ≤ 50,000 and/or INR\> 1.5).
  • History of allergic reactions to local anesthetics.
  • Rash or signs of infection at the injection site.
  • Emergency surgery.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Kasralainy

Cairo, 11559, Egypt

Location

MeSH Terms

Conditions

Pain

Condition Hierarchy (Ancestors)

Neurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Khaled Sarhan, MD

    Lecturer of anesthesia, Cairo university

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Study will be conducted on 60 adults aged from 18 to 60 years presented for major abdominal surgeries (open colorectal resections or major ventral hernia repair) at general surgery operating theatres, Cairo university hospitals. Patients will be divided into two equal groups; rectus sheath block group RSB (n=30) and erector spinae plane block group ESPB (n=30).
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
principal investigator

Study Record Dates

First Submitted

January 12, 2020

First Posted

January 18, 2020

Study Start

January 1, 2020

Primary Completion

March 1, 2021

Study Completion

March 1, 2021

Last Updated

March 16, 2021

Record last verified: 2021-03

Locations